Skip to main content
See every side of every news story
Published loading...Updated

Innate Pharma to Participate in the Kempen Life Sciences Conference

MARSEILLE, France--(BUSINESS WIRE)--#Biotech--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in one-on-one investor meetings at the following conference: Kempen Life Sciences Conference Dates: April 15 –16, 2026 Location: Amsterdam, Netherlan…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

innate-pharma.cominnate-pharma.com
Reposted by
HealthTech HotSpotHealthTech HotSpot

Innate Pharma to participate in the Kempen Life Sciences conference Fri, 04/03/2026 - 07:00 Press release in English 139 KB Communiqué de presse en français 131.63 KB helene Thu, 04/02/2026

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

innate-pharma.com broke the news in on Thursday, April 2, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal